These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

216 related articles for article (PubMed ID: 27126786)

  • 21. Glycoproteomics Technologies in Glycobiotechnology.
    Alagesan K; Hoffmann M; Rapp E; Kolarich D
    Adv Biochem Eng Biotechnol; 2021; 175():413-434. PubMed ID: 33205259
    [TBL] [Abstract][Full Text] [Related]  

  • 22. A framework for real-time glycosylation monitoring (RT-GM) in mammalian cell culture.
    Tharmalingam T; Wu CH; Callahan S; T Goudar C
    Biotechnol Bioeng; 2015 Jun; 112(6):1146-54. PubMed ID: 25545171
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Characterization of oligosaccharides in recombinant tissue plasminogen activator produced in Chinese hamster ovary cells: two decades of analytical technology development.
    Borisov OV; Field M; Ling VT; Harris RJ
    Anal Chem; 2009 Dec; 81(23):9744-54. PubMed ID: 19947664
    [TBL] [Abstract][Full Text] [Related]  

  • 24. FTIR spectroscopy as an analytical tool to compare glycosylation in therapeutic monoclonal antibodies.
    Derenne A; Derfoufi KM; Cowper B; Delporte C; Goormaghtigh E
    Anal Chim Acta; 2020 May; 1112():62-71. PubMed ID: 32334683
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Low-flow sheathless capillary electrophoresis-mass spectrometry for sensitive glycoform profiling of intact pharmaceutical proteins.
    Haselberg R; de Jong GJ; Somsen GW
    Anal Chem; 2013 Feb; 85(4):2289-96. PubMed ID: 23323765
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The significance of glycosylation analysis in development of biopharmaceuticals.
    Kawasaki N; Itoh S; Hashii N; Takakura D; Qin Y; Huang X; Yamaguchi T
    Biol Pharm Bull; 2009 May; 32(5):796-800. PubMed ID: 19420744
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Plant-specific glycosylation patterns in the context of therapeutic protein production.
    Gomord V; Fitchette AC; Menu-Bouaouiche L; Saint-Jore-Dupas C; Plasson C; Michaud D; Faye L
    Plant Biotechnol J; 2010 Jun; 8(5):564-87. PubMed ID: 20233335
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Comparison of orthogonal chromatographic and lectin-affinity microarray methods for glycan profiling of a therapeutic monoclonal antibody.
    Cook MC; Kaldas SJ; Muradia G; Rosu-Myles M; Kunkel JP
    J Chromatogr B Analyt Technol Biomed Life Sci; 2015 Aug; 997():162-78. PubMed ID: 26114652
    [TBL] [Abstract][Full Text] [Related]  

  • 29. A rapid mass spectrometric strategy for the characterization of N- and O-glycan chains in the diagnosis of defects in glycan biosynthesis.
    Faid V; Chirat F; Seta N; Foulquier F; Morelle W
    Proteomics; 2007 Jun; 7(11):1800-13. PubMed ID: 17520685
    [TBL] [Abstract][Full Text] [Related]  

  • 30. N-Glycosylation of monoclonal antibody therapeutics: A comprehensive review on significance and characterization.
    Shrivastava A; Joshi S; Guttman A; Rathore AS
    Anal Chim Acta; 2022 May; 1209():339828. PubMed ID: 35569847
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Particle sizing methods for the detection of protein aggregates in biopharmaceuticals.
    Khodabandehloo A; Chen DD
    Bioanalysis; 2017 Feb; 9(3):313-326. PubMed ID: 28098491
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Mass spectrometric glycoform profiling of the innovator and biosimilar erythropoietin and darbepoetin by LC/ESI-MS.
    Harazono A; Hashii N; Kuribayashi R; Nakazawa S; Kawasaki N
    J Pharm Biomed Anal; 2013 Sep; 83():65-74. PubMed ID: 23708432
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Comparison of glycoprofiles of rituximab versions licensed for sale in India and an analytical approach for quality assessment.
    Kaur T; Shukla BN; Yadav VK; Kulkarni MJ; Rao A
    J Proteomics; 2021 Jul; 244():104267. PubMed ID: 34015520
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Comprehensive N-Glycan Profiling of Cetuximab Biosimilar Candidate by NP-HPLC and MALDI-MS.
    Liu S; Gao W; Wang Y; He Z; Feng X; Liu BF; Liu X
    PLoS One; 2017; 12(1):e0170013. PubMed ID: 28072827
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Chemical Methods for Encoding and Decoding of Posttranslational Modifications.
    Chuh KN; Batt AR; Pratt MR
    Cell Chem Biol; 2016 Jan; 23(1):86-107. PubMed ID: 26933738
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Host Cell Proteins: The Hidden Side of Biosimilarity Assessment.
    Mihara K; Ito Y; Hatano Y; Komurasaki Y; Sugimura A; Jones M; Liu H; Mai S; Lara-Velasco O; Bai L; Ketkar A; Adams M; Hirato T; Ionescu R
    J Pharm Sci; 2015 Dec; 104(12):3991-3996. PubMed ID: 26367379
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Brilliant glycans and glycosylation: Seq and ye shall find.
    Gao G; Li C; Fan W; Zhang M; Li X; Chen W; Li W; Liang R; Li Z; Zhu X
    Int J Biol Macromol; 2021 Oct; 189():279-291. PubMed ID: 34389387
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Posttranslational modifications of intact proteins detected by NMR spectroscopy: application to glycosylation.
    Schubert M; Walczak MJ; Aebi M; Wider G
    Angew Chem Int Ed Engl; 2015 Jun; 54(24):7096-100. PubMed ID: 25924827
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Analyzing protein glycosylation using UHPLC: a review.
    Rowe L; Burkhart G
    Bioanalysis; 2018 Oct; 10(20):1691-1703. PubMed ID: 30412689
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Engineering yeast for producing human glycoproteins: where are we now?
    Laukens B; De Visscher C; Callewaert N
    Future Microbiol; 2015; 10(1):21-34. PubMed ID: 25598335
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.